Author:
Nasu Yasutomo,Watanabe Masami
Reference26 articles.
1. http://www.wiley.co.uk/genmed/clinical
2. Nasu Y, et al. Suicide gene therapy with adenoviral delivery of HSV-tK gene for patients with local recurrence of prostate cancer after hormonal therapy. Mol Ther. 2007;15(4):834–40.
3. Kumon H. Clinical development of gene therapy and gene medicine based on the novel tumor suppressor gene REIC/Dkk-3 (article in Japanese). MOOK 17 (Kawakami Koji). 2010; p. 132–7.
4. Galsky MD, et al. Docetaxel-based combination therapy for castration-resistant prostate cancer. Ann Oncol. 2010;21(15):2135–44.
5. Mitchell E, et al. MDA-7/IL-24: multifunctional cancer killing cytokine. Adv Exp Med Biol. 2014;818(1):127–53.